Browse All

Current Filters

CLEAR FILTER x

TITLE

Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study

Author:Hygge Blakeman, Karin   Urani, Alexandre   Lambru, Giorgio   Lipton, Richard   Goadsby, Peter   Pozo-Rosich, Patricia   Schwedt, Todd   Fanning, Kristina   Dai, Feng   Abraham, Lucy   

Session Name:P8: Headache: Acute, Rescue, and Short-term Prevention Migraine Pharmacologic Treatment  

Topic:Headache  

Program Number:P8.018  

Author Institution:Pfizer AB., Stockholm, Sweden  Aptar Digital Health, Paris, France  Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom  Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY  King’s College London, London, United Kingdom  Universitat Autònoma de Barcelona, Barcelona, Spain  Mayo Clinic, Phoenix, AZ  MIST Reserach, Wilmington, NC  Pfizer Inc., New York, NY  Pfizer R&D UK Ltd., Tadworth, United Kingdom  

Reassessing Amyloid Modulation: Clinical Efficacy and Safety of Valiltramiprosate in Alzheimer's Disease

Author:Kaurani, Purvi   Gupta, Shikha   Patidar, krishna   Metukuru, Bhavana   Joshi, Amit   M, Tanishka   Mozafari, Parvin   Srijamya, N/A   

Session Name:P1: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease and Anti-amyloid Therapies 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P1.007  

Author Institution:D.Y. Patil University School of Medicine, Navi Mumbai, Maharashtra, India  Fortis Hospital, Mohali, Punjab, India  Jinan University School of Medicine, Guangzhou, China, People's Republic of  Government Medical College, Suryapet, India  Chongqing Medical University, Chongqing, China, People's Republic of  ACS Medical College and Hospital, Chennai, Tamil Nadu, India  University of Georgia, Tbilisi, Georgia  Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia  

Receptor Selectivity Profile and Clinical Significance of Ecopipam and Relevant Metabolites: A Potential New Treatment for Tourette Syndrome (TS)

Author:Wanaski, Stephen   Schmith, Virginia   Karkanias, George   Cunniff, Timothy   

Session Name:P2: Movement Disorders: Hyperkinetic Movement Disorders 1  

Topic:Movement Disorders  

Program Number:P2.002  

Author Institution:Paragon Biosciences, LLC, Chicago, IL  2Schmith PK/PD Consulting, LLC, Cocoa Beach, FL  Emalex Biosciences, Inc., Ridgewood, NJ  Paragon Biosciences, LLC, IL  

Reciprocal Relationship Between Early Reperfusion and First-pass Effect in Tenecteplase versus Alteplase before Stroke Thrombectomy

Author:Kline, Kelsey   Bielinski, Tyler   Badger, Grant   Bohl, Veronica   Hemmer, Sina   Stedman, Wysteria   Goren, Oded   Li, Jiang   Schirmer, Clemens   Hendrix, Philipp   

Session Name:P5: Cerebrovascular Disease and Interventional Neurology: Stroke Treatment, Outcomes, and Rehabilitation Strategies 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P5.001  

Author Institution:Geisinger College of Health Sciences, Spring Brook Twp, PA  Geisinger College of Health Sciences, Dunmore, PA  Geisinger College of Health Sciences, Mantorville, MN  Geisinger College of Health Sciences, Scranton, PA  Geisinger Wyoming Valley, Wilkes Barre, PA  Geisinger Medical Center, Danville, PA  Weis Center for Research, Geisinger, PA  

Recognizing Amyotrophic Lateral Sclerosis Early: Bilateral Internal Capsule Hyperintensities as a Diagnostic Clue

Author:Shahrigian, Taleen   Schick, Jason   Gilbert, Christopher   Antonio, Aileen   Goshgarian, Christopher   Taylor, Melanie   Phillips, Joel   

Session Name:P3: Neuromuscular and Clinical Neurophysiology (EMG): Case Studies in Neuromuscular Medicine 2  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P3.012  

Author Institution:Trinity Health Grand Rapids, Grand Rapids, MI  Trinity Health Saint Mary's Hauenstein Neurosciences, Grand Rapids, MI  Trinity Health Grand Rapids , Ada, MI  Trinity Health Grand Rapids , Grand Rapids, MI